MedTrace Logo

Usability Study of the Sensors and eMOM GDM Application

NCT03941652 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2025-03-11

No results posted yet for this study

Summary

The principal aim of the eMOM GDM-project is to evaluate the effect of the eMOM GDM -application and the integrated service concept model on maternal and neonatal outcomes.

In the first phase of the project the investigators evaluate the usability, functionality and acceptability of developed eMOM GDM application and used sensors (continuous glucose meter, accelerometer, speech-enabled food record, optical pulse, beat-to-beat heart rate). Two different user interfaces (one for the women with GDM and one for the health care professionals) of the eMOM GDM application will we be developed and evaluated.

Conditions

  • Gestational Diabetes

Sponsors & Collaborators

  • Business Finland

    collaborator OTHER

  • Aalto University

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Fujitsu Finland Oy

    collaborator UNKNOWN

  • Elisa Oyj

    collaborator UNKNOWN

  • CleverHealth Network

    collaborator UNKNOWN

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Seppo T Heinonen, prof · Helsinki University Hospital, Women's Hospital

Eligibility

Min Age
18 Years
Max Age
68 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-27
Primary Completion
2022-10-30
Completion
2026-12-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941652 on ClinicalTrials.gov